Merck to Aquire Terns Pharmaceuticals Expanding Its Hematology Pipeline with Tern-701, A Novel Candidate for Chronic Myeloid Leukemia

Merck & Terns Pharmaceuticals in the NEWS  March 25, 2026 (GLOBE NEWSWIRE) -- Merck ( MRK ) - known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) ( TERN ) -...